• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国风湿病学会在 COVID-19 大流行期间成人患者风湿性疾病管理指南:第 1 版。

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1.

机构信息

University of Nebraska Medical Center, Omaha, Nebraska and VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska.

Toronto Western Hospital, Mount Sinai Hospital, and University of Toronto, Toronto, Ontario, Canada.

出版信息

Arthritis Rheumatol. 2020 Aug;72(8):1241-1251. doi: 10.1002/art.41301. Epub 2020 Jun 5.

DOI:10.1002/art.41301
PMID:32349183
Abstract

OBJECTIVE

To provide guidance to rheumatology providers on the management of adult rheumatic disease in the context of the coronavirus disease 2019 (COVID-19) pandemic.

METHODS

A task force, including 10 rheumatologists and 4 infectious disease specialists from North America, was convened. Clinical questions were collated, and an evidence report was rapidly generated and disseminated. Questions and drafted statements were reviewed and assessed using a modified Delphi process. This included 2 rounds of asynchronous anonymous voting by e-mail and 3 webinars with the entire panel. Task force members voted on agreement with draft statements using a 1-9-point numerical scoring system, and consensus was determined to be low, moderate, or high based on the dispersion of votes. For approval, median votes were required to meet predefined levels of agreement (median values of 7-9, 4-6, and 1-3 defined as agreement, uncertainty, or disagreement, respectively) with either moderate or high levels of consensus.

RESULTS

The task force approved 77 initial guidance statements: 36 with moderate and 41 with high consensus. These were combined, resulting in 25 final guidance statements.

CONCLUSION

These guidance statements are provided to promote optimal care during the current pandemic. However, given the low level of available evidence and the rapidly evolving literature, this guidance is presented as a "living document," and future updates are anticipated.

摘要

目的

为风湿病医生在 2019 年冠状病毒病(COVID-19)大流行背景下管理成人风湿性疾病提供指导。

方法

召集了一个由 10 名来自北美的风湿病专家和 4 名传染病专家组成的工作组。整理了临床问题,并迅速生成和发布了一份证据报告。通过修改后的德尔菲法对问题和起草的陈述进行了审查和评估。这包括两轮电子邮件异步匿名投票和与整个专家组的 3 次网络研讨会。工作组成员使用 1-9 分的数字评分系统对草案声明的一致性进行投票,根据投票的分散程度,共识被确定为低、中或高。为了获得批准,中位数投票需要达到预先设定的协议水平(中位数为 7-9、4-6 和 1-3 分别定义为协议、不确定性或不同意),且共识水平为中等或高。

结果

工作组批准了 77 条初始指导声明:36 条为中等共识,41 条为高共识。这些声明被合并,最终产生了 25 条最终指导声明。

结论

这些指导声明旨在促进当前大流行期间的最佳护理。然而,鉴于现有证据水平低且文献快速发展,该指南被视为“活文档”,预计未来会进行更新。

相似文献

1
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1.美国风湿病学会在 COVID-19 大流行期间成人患者风湿性疾病管理指南:第 1 版。
Arthritis Rheumatol. 2020 Aug;72(8):1241-1251. doi: 10.1002/art.41301. Epub 2020 Jun 5.
2
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3.美国风湿病学会在 COVID-19 大流行期间成人患者风湿病管理指南:第 3 版。
Arthritis Rheumatol. 2021 Feb;73(2):e1-e12. doi: 10.1002/art.41596. Epub 2020 Dec 5.
3
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2.美国风湿病学会在 COVID-19 大流行期间成人风湿性疾病管理指南:第 2 版。
Arthritis Rheumatol. 2020 Sep;72(9):e1-e12. doi: 10.1002/art.41437. Epub 2020 Jul 30.
4
American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 2.美国风湿病学会关于 COVID-19 大流行期间儿童风湿病管理的指南:第 2 版。
Arthritis Rheumatol. 2021 Aug;73(8):e46-e59. doi: 10.1002/art.41772. Epub 2021 Jun 10.
5
American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 1.美国风湿病学会关于 COVID-19 大流行期间儿童风湿病管理的指南:第 1 版。
Arthritis Rheumatol. 2020 Nov;72(11):1809-1819. doi: 10.1002/art.41455. Epub 2020 Sep 28.
6
Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020.管理 COVID-19 大流行期间的风湿性疾病患者:法国风湿病学会回答了截至 2020 年 5 月最常被问到的问题。
Joint Bone Spine. 2020 Oct;87(5):431-437. doi: 10.1016/j.jbspin.2020.05.006. Epub 2020 May 27.
7
Rheumatologists' practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt.风湿科医生在 2019 冠状病毒病(COVID-19)大流行期间的实践:埃及的一项调查。
Rheumatol Int. 2020 Oct;40(10):1599-1611. doi: 10.1007/s00296-020-04655-9. Epub 2020 Jul 24.
8
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.国家银屑病基金会 COVID-19 工作组关于大流行期间银屑病管理的指南:第 1 版。
J Am Acad Dermatol. 2020 Dec;83(6):1704-1716. doi: 10.1016/j.jaad.2020.09.001. Epub 2020 Sep 4.
9
Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology.关于2019冠状病毒病(COVID-19)感染背景下成年风湿性疾病患者管理的建议。哥伦比亚风湿病学会。
Reumatol Clin (Engl Ed). 2020 Nov-Dec;16(6):437-446. doi: 10.1016/j.reuma.2020.06.011. Epub 2020 Jul 28.
10
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.风湿性疾病患者因 COVID-19 住院的相关特征:来自 COVID-19 全球风湿病联盟医生报告登记处的数据。
Ann Rheum Dis. 2020 Jul;79(7):859-866. doi: 10.1136/annrheumdis-2020-217871. Epub 2020 May 29.

引用本文的文献

1
Treating rheumatoid arthritis in Zanzibar: a cost effectiveness study comparing conventional, biologic, and targeted-synthetic disease modifying anti-rheumatic drugs.桑给巴尔类风湿关节炎的治疗:一项比较传统、生物和靶向合成改善病情抗风湿药物的成本效益研究。
Front Med (Lausanne). 2025 Aug 20;12:1618493. doi: 10.3389/fmed.2025.1618493. eCollection 2025.
2
What the SARS-CoV-2 Pandemic Has Taught Us About Immunosuppression, Vaccinations, and Immune Dysregulation: The Rheumatology Experience.SARS-CoV-2 大流行让我们了解到免疫抑制、疫苗接种和免疫失调:风湿病学的经验。
Curr Allergy Asthma Rep. 2024 Apr;24(4):221-232. doi: 10.1007/s11882-024-01139-9. Epub 2024 Apr 3.
3
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase.
新冠疫情及疫苗接种运动对大流行头三年中1755例系统性硬化症患者的影响。在下一疫情阶段,免疫反应受损者、正在接受免疫调节治疗者以及患有疾病相关肺部病变者面临的潜在风险。
J Transl Autoimmun. 2023 Oct 9;7:100212. doi: 10.1016/j.jtauto.2023.100212. eCollection 2023 Dec.
4
Communication to promote and support physical distancing for COVID-19 prevention and control.促进和支持预防和控制 COVID-19 的物理隔离的沟通。
Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD015144. doi: 10.1002/14651858.CD015144.
5
Telemedicine for follow-up of systemic lupus erythematosus during the 2019 coronavirus pandemic: A pragmatic randomized controlled trial.2019年冠状病毒大流行期间系统性红斑狼疮随访的远程医疗:一项实用随机对照试验
J Telemed Telecare. 2025 Feb;31(2):222-230. doi: 10.1177/1357633X231181714. Epub 2023 Jun 26.
6
Clinical course and prognostic factors of COVID-19 infection in patients with chronic inflammatory-rheumatic disease: A retrospective, case-control study.慢性炎症性风湿性疾病患者感染新型冠状病毒肺炎的临床病程及预后因素:一项回顾性病例对照研究
Arch Rheumatol. 2022 Sep 20;38(1):44-55. doi: 10.46497/ArchRheumatol.2023.9289. eCollection 2023 Mar.
7
Learning from the COVID-19 pandemic: health care disturbances and telemedicine as an alternative rheumatology practice in Indonesia.从 COVID-19 大流行中学习:印度尼西亚的医疗保健干扰和远程医疗作为替代风湿病实践。
BMC Health Serv Res. 2023 May 8;23(1):451. doi: 10.1186/s12913-023-09389-5.
8
Cross-sectional study of COVID-19 infection in patients with rheumatic diseases in a sample of a Damascene population, Syria.叙利亚大马士革人群样本中风湿病患者新冠病毒感染的横断面研究。
Ann Med Surg (Lond). 2023 Mar 14;85(4):689-693. doi: 10.1097/MS9.0000000000000274. eCollection 2023 Apr.
9
Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic Review.COVID-19 大流行对慢性病治疗依从性的影响:系统评价。
Int J Environ Res Public Health. 2023 Feb 21;20(5):3825. doi: 10.3390/ijerph20053825.
10
Locomotive syndrome in rheumatoid arthritis patients during the COVID-19 pandemic.类风湿关节炎患者在 COVID-19 大流行期间的运动障碍综合征。
Nagoya J Med Sci. 2022 Nov;84(4):799-812. doi: 10.18999/nagjms.84.4.799.